Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients
Key facts
- Who runs it
- University of Vermont
- Where
- Burlington, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 5 Feb 2026
- Expected to end
- 22 Jul 2027
- Type of study
- Interventional
- Treatments tested
- Prolonged exposure therapy + incentives for therapy session attendance
- Record updated
- 13 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Female
- >18 years old
- Gestational age ≤ 25 weeks
- Meet current DSM-5 posttraumatic stress disorder criteria based on the Clinician Administered PTSD Scale for DSM-5
- Participants receiving psychotropic medications must be maintained on a stable dose for >14 days prior to enrollment
Who cannot take part
- Current delusions or hallucinations, unstable bipolar disorder, imminent risk for suicide as assessed by the Mini International Neuropsychiatric Interview
- Under 18 years old
- Gestational age > 25 weeks
- Male
- No current diagnosis of PTSD
- Enrolled in another ongoing evidence-based treatment for PTSD
This trial is currently available in United States.
- University of VermontBurlington, United StatesContact: Kelly PeckTaking people
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if a treatment for adults with PTSD called prolonged exposure + incentives (PE+) works to treat pregnant patients. The main question it aims to answer is:
Read full original descriptionShow less
Does PE+ decrease PTSD symptoms?
All participants will receive PE+ to see if their PTSD symptoms at the end of the trial are less than at the beginning.
Participants will:
* Receive individual PE+ therapy for 1 hour weekly for 12 weeks. * Receive financial incentives for attending each PE+ session. * Attend assessment visits every 4 weeks for the 12 weeks of the trial. * Allow research staff to collect some information about their labor and delivery from their medical records after their babies are born.
The group in the trial
- Prolonged exposure therapy + incentives for therapy session attendanceTreatment being tested
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 13 May 2026